Form4insider filings, from the source

Insider holders · CIK 0001690585

Dianthus Therapeutics, Inc. /DE/ · DNTH

Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity

InsiderDirect sharesIndirect sharesTotal reportedLast report (ET)From
Third Rock Ventures IV, L.P.10% Owner8,008,204—8,008,204Jun 27, 2018 · 4:34 pm EDTForm 4
Third Rock Ventures GP IV, L.P.10% Owner8,008,204—8,008,204Jun 27, 2018 · 4:34 pm EDTForm 4
TRV GP IV, LLC10% Owner8,008,204—8,008,204Jun 27, 2018 · 4:34 pm EDTForm 4
ATLAS VENTURE ASSOCIATES X, L.P.10% Owner4,843,625—4,843,625Jun 27, 2018 · 4:36 pm EDTForm 4
Atlas Venture Associates X, LLC10% Owner4,843,625—4,843,625Jun 27, 2018 · 4:36 pm EDTForm 4
Atlas Venture Fund X, L.P.10% Owner4,843,625—4,843,625Jun 27, 2018 · 4:36 pm EDTForm 4
Bruce BoothDirector—4,843,6254,843,625Jun 27, 2018 · 4:28 pm EDTForm 4
Blake ByersDirector—3,339,1373,339,137Jun 27, 2018 · 4:25 pm EDTForm 4
GV 2016 GP, L.P.10% Owner—3,339,1373,339,137Jun 27, 2018 · 4:28 pm EDTForm 4
GV 2016 GP, L.L.C.10% Owner—3,339,1373,339,137Jun 27, 2018 · 4:28 pm EDTForm 4
GV 2016, L.P.10% Owner—3,339,1373,339,137Jun 27, 2018 · 4:28 pm EDTForm 4
Alphabet Inc.10% Owner—3,339,1373,339,137Jun 27, 2018 · 4:28 pm EDTForm 4
David ScaddenDirector228,175580,499808,674Jun 27, 2018 · 4:36 pm EDTForm 4
Jason GardnerSee Remarks363,212359,092722,304Jun 27, 2018 · 4:24 pm EDTForm 4
Amy L RonnebergDirector—593,611593,611Jun 27, 2018 · 4:31 pm EDTForm 4
Michael P. CookeChief Scientific Officer293,023—293,023Jun 27, 2018 · 4:30 pm EDTForm 4
Michael W BonneyDirector215,346—215,346Jun 27, 2018 · 4:27 pm EDTForm 4
Zoran ZdraveskiSee Remarks140,092—140,092Jun 27, 2018 · 4:30 pm EDTForm 4
Christina K. IsacsonChief Business Officer103,531—103,531Jun 27, 2018 · 4:30 pm EDTForm 4
Thomas O DanielDirector101,926—101,926Jun 27, 2018 · 4:34 pm EDTForm 4
Marino GarciaCEO AND PRESIDENT65,292—65,292Aug 7, 2026 · 6:30 pm EDTForm 4
Adam M VenessSVP, General Counsel and Sec.15,000—15,000Aug 14, 2026 · 4:30 pm EDTForm 4
John C. Davis Jr.Chief Medical Officer8,304—8,304Jun 27, 2018 · 4:24 pm EDTForm 4
Jeffrey W. AlbersDirector4,152—4,152Jun 27, 2018 · 4:27 pm EDTForm 4
Simrat RandhawaEVP, Head of R&D4,000—4,000Sep 3, 2026 · 4:30 pm EDTForm 4
Ryan SavitzEVP, CFO & CBO0—0Jul 13, 2026 · 5:00 pm EDTForm 4
Anne McGeorgeDirector0—0Aug 11, 2026 · 5:15 pm EDTForm 4
Simon ReadDirector0—0Aug 19, 2026 · 6:02 pm EDTForm 4
Alexis BorisyDirector—00Jun 27, 2018 · 4:24 pm EDTForm 4
Edward CarrCHIEF ACCOUNTING OFFICER0—0Sep 18, 2026 · 4:36 pm EDTForm 4

Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.